BXSY (Bexil Investment Trust) reported FY 2025 results for the year ended Dec. 31, 2025, including a net investment loss of USD 1.9 million, net realized gains on investments of USD 11.3 million and a net increase in unrealized appreciation on investments of USD 56.3 million, driving a net increase in net assets from operations of USD 65.6 million. Net assets were USD 306.1 million at period-end, with net asset value per share of USD 23.66. The fund reported a FY 2025 net asset value total return of 29.7% and a market price total return of 32.3%. BXSY said it declared its fourth quarterly distribution of FY 2025 at USD 0.25 per share on Dec. 1, 2025, and indicated the distribution was estimated to be sourced approximately 100% from capital gains for Q4. The fund also said it anticipates raising the quarterly distribution to USD 0.26 per share for each quarter of 2026. Management highlighted a focus during the year on income-generating equities of “profitable, growing, and conservatively valued” companies, and noted that Lam Research contributed to unrealized appreciation while UnitedHealth contributed to unrealized depreciation; it also cited realized gains from sales including New Gold and realized losses including Crocs.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bexil Investment Fund published the original content used to generate this news brief on March 05, 2026, and is solely responsible for the information contained therein.
Comments